Chiome Bioscience Inc. (4583.T)
JPY 134.0
(0.75%)
JPY 134.0
(0.75%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 682.46 Million JPY | 8.19% |
| 2022 | 630.81 Million JPY | -11.52% |
| 2021 | 712.93 Million JPY | 48.26% |
| 2020 | 480.85 Million JPY | 7.43% |
| 2019 | 447.57 Million JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 134.08 Million JPY | 3.42% |
| 2024 Q1 | 129.64 Million JPY | -18.18% |
| 2023 Q3 | 165.13 Million JPY | -12.85% |
| 2023 Q2 | 189.48 Million JPY | 11.85% |
| 2023 Q1 | 169.4 Million JPY | -14.06% |
| 2023 FY | 682.46 Million JPY | 8.19% |
| 2023 Q4 | 158.44 Million JPY | -4.05% |
| 2022 Q3 | 155.48 Million JPY | 0.0% |
| 2022 FY | 630.81 Million JPY | -11.52% |
| 2022 Q4 | 197.12 Million JPY | 26.78% |
| 2021 FY | 712.93 Million JPY | 48.26% |
| 2020 FY | 480.85 Million JPY | 7.43% |
| 2019 FY | 447.57 Million JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | 85.693% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -504.346% |
| GNI Group Ltd. | 26.01 Billion JPY | 97.376% |
| Linical Co., Ltd. | 12.3 Billion JPY | 94.455% |
| Trans Genic Inc. | 13.08 Billion JPY | 94.784% |
| MEDINET Co., Ltd. | 661.54 Million JPY | -3.162% |
| Soiken Holdings Inc. | 5.15 Billion JPY | 86.77% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | 56.263% |
| AnGes, Inc. | 152.98 Million JPY | -346.099% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | -11.858% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 94.654% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | 16.436% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | -403.634% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | 58.025% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | -59.319% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | 64.104% |
| Kidswell Bio Corporation | 2.43 Billion JPY | 71.929% |
| PeptiDream Inc. | 28.71 Billion JPY | 97.623% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -982.623% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -464.02% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -947766.667% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -1610.994% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | 84.87% |
| FunPep Company Limited | 530 Thousand JPY | -128666.792% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -885.508% |
| Stella Pharma Corporation | 269.49 Million JPY | -153.242% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | -115.412% |
| Cuorips Inc. | 23.1 Million JPY | -2854.134% |
| K Pharma,Inc. | 1 Billion JPY | 31.754% |
| Takara Bio Inc. | 43.5 Billion JPY | 98.431% |
| ReproCELL Incorporated | 2.42 Billion JPY | 71.878% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | 60.214% |
| StemCell Institute Inc. | 2.48 Billion JPY | 72.495% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | 72.856% |
| CellSeed Inc. | 190.13 Million JPY | -258.938% |